COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,696 Articles (22,913 medRxiv, 8,783 bioRxiv)

Most recent first Previous |  Page 313: Articles 3121-3130  | Next

Feasibility and preliminary efficacy of an online mindful walking intervention among COVID-19 long haulers: A mixed method study including daily diary surveys
Aggarwal, A., Qiao, S., Yang, C.-H., Taylor, S., Tam, C. C., Li, X.
10.1101/2024.01.23.24301694 — Posted: 2024-01-29
Mathematical model of replication-mutation dynamics in coronaviruses
Blyuss, K. B., Kyrychko, Y. N.
10.1101/2024.01.29.577716 — Posted: 2024-01-29
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients
Santos, R., Moreno-Torres, V., Pintos, I., Corral, O., de Mendoza, C., Soriano, V., Corpas, M.
10.1101/2024.01.28.577610 — Posted: 2024-01-29
Multiple layers of innate immune response antagonism of SARS-CoV-2
Zhou, F., Periasamy, S., Jackson, N., Cheng, W. S., Soto Acosta, R., Ilinykh, P., Ye, C., Chauhan, S., Nudelman, G., Zaslavsky, E., Widen, S., Martinez-Sobrido, L., Sealfon, S., Bukreyev, A.
10.1101/2024.01.29.577695 — Posted: 2024-01-29
Discovery of orally active SARS-CoV-2 papain-like protease (PLpro) inhibitors
Garnsey, M. R., Robinson, M. C., Nguyen, L. T., Cardin, R., Tillotson, J., Mashalidis, E., Aijia, Y., Aschenbrenner, L., Balesano, A., Behzadi, A., Boras, B., Chang, J. S., Eng, H., Ephron, A., Foley, T., Ford, K., Frick, J. M., Gibson, S., Li, H., Hurst, B., Kalgutkar, A. S., Korczynska, M., Lengyel-Zhand, Z., Liping, G., Meredith, H. R., Patel, N. C., Polivkova, J., Rai, D., Rose, C. R., Rothan, H., Sakata, S. K., Vargo, T. R., Qi, W., Wu, H., Liu, Y., Yurgelonis, I., Zhang, J., Zhu, Y., Zhang, L., Lee, A. A.
10.1101/2024.01.26.577395 — Posted: 2024-01-29
Impact of the COVID-19 Pandemic on Undergraduate Research in the Department of Biology at Western University: Effect on project types, learning outcomes, and student perceptions.
Chaplin, A., Kohalmi, S. E., Simon, A. F.
10.1101/2024.01.24.577125 — Posted: 2024-01-28
Predicting COVID-19 cases across a large university campus using complementary built environment and wastewater surveillance approaches
Hinz, A., Moggridge, J. A., Ke, H., Hicks, A. M. A., Doukhanine, E., Fralick, M., Hug, L., MacFadden, D., Mejbel, H., Nott, C., Raudanskis, A., Thampi, N., Wong, A., Kassen, R.
10.1101/2024.01.24.23300025 — Posted: 2024-01-26
Superspreading of SARS-CoV-2: a systematic review and meta-analysis of event attack rates and individual transmission patterns
McKee, C. D., Yu, E. X., Garcia, A., Jackson, J., Koyuncu, A., Rose, S., Azman, A. S., Lobner, K., Sacks, E., Van Kerkhove, M. D., Gurley, E. S.
10.1101/2024.01.25.24301669 — Posted: 2024-01-26
An ecological study of COVID-19 outcomes among Florida counties
Ali, S., Azarian, T.
10.1101/2024.01.26.24301823 — Posted: 2024-01-26
In silico assessment of immune cross protection between BCoV and SARS-CoV-2
Beirao, B. C. B., Querne, L. B., Zettel Bastos, F., Adur, M. d. A., Cavalheiro, V. L.
10.1101/2024.01.25.577193 — Posted: 2024-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).